October 9th 2025, 9:00pm
By Gina Mauro
Understand why early detection gives you the best chance, explore your surgery or radiation options, and plan for survivorship with oral cavity cancer.
October 9th 2025, 8:00pm
By Ryan Scott
Young women with breast cancer experience significant declines in body image, sexual satisfaction, and sexual interest both during and after treatment.
October 9th 2025, 7:00pm
By Spencer Feldman
Dr. Vishal Patel explains what Libtayo’s FDA approval means for patients with high-risk cutaneous squamous cell carcinoma.
October 9th 2025, 5:00pm
By Natasha Carlson
As a survivor, I see pink ribbons everywhere, but what we really need is more research, better treatments, and real change for those living with cancer.
October 9th 2025, 3:59pm
Dr. Patrick J. Hensley explains non-muscle invasive bladder cancer, bladder-preserving treatments, trial eligibility, novel therapies and research priorities for patients.
October 9th 2025, 3:00pm
By Alex Biese
The FDA granted fast track designation to VT3989 for unresectable malignant nonpleural or pleural mesotherlioma.
October 9th 2025, 1:00pm
By Dr. Ravi Munver
Dr. Ravi Munver highlights how minimally invasive treatment has improved recovery and quality, improving outcomes for patients with kidney cancer
October 8th 2025, 9:00pm
Remote monitoring has been found to be associated with improved postsurgical recovery for patients with cancer.
October 8th 2025, 8:00pm
By Dr. Sheldon Marc Feldman
Dr. Sheldon Marc Feldman explores Reiki’s potential to reduce stress and anxiety for patients undergoing breast cancer surgery at Montefiore Einstein Comprehensive Cancer Center.
October 8th 2025, 7:04pm
The FDA has approved Libtayo for the postsurgical treatment of adults with cutaneous squamous cell carcinoma.
October 8th 2025, 5:00pm
By Carla Deschamps
At the age of 34, I received the biggest news of my life, which was my diagnosis with colon cancer. I remember that day like it was yesterday.
October 8th 2025, 4:00pm
Although death rates continue to decline each year, prostate cancer cases are increasing, especially those diagnosed at advanced stages.
October 8th 2025, 3:04pm
The FDA granted fast track status to UB-VV111 for patients with relapsed or refractory large B-cell lymphoma or chronic lymphocytic leukemia.
October 8th 2025, 1:00pm
By Dr. Evan Garfein
Dr. Evan Garfein said 3D printing and tissue-engineered implants may make breast reconstruction safer, more personalized and less physically taxing.
October 7th 2025, 9:00pm
By Debbie Legault
It’s October, and social media sites are full of vendors selling merchandise featuring pink ribbons. But here's the thing...
Stage 1 Multiple Myeloma Treatment Options and Side Effect Management
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
Understanding Your Stage 2 Ovarian Cancer
A Breast Cancer Survivor's Delightful Dilemma